Coordinatore | CONSIGLIO NAZIONALE DELLE RICERCHE
Organization address
address: Piazzale Aldo Moro 7 contact info |
Nazionalità Coordinatore | Italy [IT] |
Sito del progetto | http://www.dorian-fp7.eu/ |
Totale costo | 3˙863˙873 € |
EC contributo | 2˙999˙973 € |
Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
Code Call | FP7-HEALTH-2011-two-stage |
Funding Scheme | CP-FP |
Anno di inizio | 2012 |
Periodo (anno-mese-giorno) | 2012-01-01 - 2014-12-31 |
# | ||||
---|---|---|---|---|
1 |
CONSIGLIO NAZIONALE DELLE RICERCHE
Organization address
address: Piazzale Aldo Moro 7 contact info |
IT (ROMA) | coordinator | 799˙994.00 |
2 |
SAMFUNDET FOLKHALSAN I SVENSKA FINLAND RF
Organization address
address: TOPELIUSGATAN 20 contact info |
FI (HELSINGFORS) | participant | 600˙000.00 |
3 |
THE UNIVERSITY OF EDINBURGH
Organization address
address: OLD COLLEGE, SOUTH BRIDGE contact info |
UK (EDINBURGH) | participant | 350˙000.00 |
4 |
TURUN YLIOPISTO
Organization address
address: YLIOPISTONMAKI contact info |
FI (TURUN YLIOPISTO) | participant | 349˙993.00 |
5 |
BIOMOL-INFORMATICS SL
Organization address
address: CALLE FARADAY -Parque Cientifico- 7 contact info |
ES (MADRID) | participant | 210˙000.00 |
6 |
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.
Organization address
address: Hofgartenstrasse 8 contact info |
DE (MUENCHEN) | participant | 200˙000.00 |
7 |
ISTITUTO SUPERIORE DI SANITA
Organization address
address: Viale Regina Elena 299 contact info |
IT (ROMA) | participant | 199˙986.00 |
8 |
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O
Organization address
address: Oskar-von-Miller-Ring 29 contact info |
DE (MUENCHEN) | participant | 195˙000.00 |
9 |
European Association for the Study of Obesity
Organization address
address: High Street 113-119 contact info |
UK (Hampton Hill) | participant | 80˙000.00 |
10 |
Mouvement Mondial des Meres - Europe
Organization address
address: Avenue Nestor Plissart 8 contact info |
BE (Bruxelles) | participant | 15˙000.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Europe has the highest proportion of elderly people in the world. Cardiovascular disease (CVD), type 2 diabetes (T2D), sarcopenia and cognitive decline frequently coexist in the same aged individual, sharing common early risk factors and being mutually reinforcing. Obesity is a main health concern in the world. In the EU one-third of women of reproductive age are overweight and 20% are obese, a prevalence predicted to double in the next decade. There is growing evidence that maternal obesity increases the long term risk of CVD, T2D and neurodegenerative morbidity in the offspring. This project will clarify if and to what extent maternal obesity leads to premature and unhealthy ageing, by causing early, i.e. pre-/perinatal metabolic and genetic vulnerability, starting from insulin resistance and glucocorticoid exposure, leading to oxidative-stress, telomere/DNA damage, epigenetic changes, interacting with genetic and environmental variability, resulting in altered gene expression/repair, and ultimately in disease during life and pathological ageing. We will investigate the postulated mechanisms during pregnancy and development, their life long consequences in animal models and in large human cohorts followed from prenatal life until ageing, and the possibility to intervene when the condition is still reversible. Surrogate markers to estimate early risk and monitor progression-regression will be defined. This project will comprehensively address the expected impacts listed in the work programme HEALTH.2011.2.2.2-2 targeting the improvement of health and healthy ageing of a broad/broadening European population. The participation of a research intensive SME and European NGOs guarantees success in biomarker discovery-innovation and in dissemination-public preventive programs. The scientific excellence and complementariness of the partners and the relevance of the target health problem will make a highly significant impact on the European policy and research in this area.'
Comprehending how maternal obesity could influence offspring health could improve the overall health of the European population. For this purpose, European scientists have set out to identify which early developmental factors determine our health and ageing.
OPtimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE)
Read MoreCare Package for Treatment and Control of Visceral Leishmaniasis in East Africa
Read MoreMissed Opportunities in Maternal and Infant Health: reducing maternal and newborn mortality and morbidity in the year after childbirth through combined facility- and community-based interventions
Read More